Trademark Overview
On Monday, July 7, 2025, a trademark application was filed for REPEAT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the REPEAT THERAPEUTICS trademark a serial number of 99269494. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 7, 2025. This trademark is owned by Repeat Therapeutics, Inc.. The REPEAT THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical compositions and preparations for the treatment of neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Pharmaceutical compositions and preparations for the treatment of amyotrophic lateral sclerosis (ALS), Parkinson's disease, multiple sclerosis (MS), Huntington’s disease (HD), Friedreich's ataxia (FA), Alzheimer's disease, motor neuron disease, cognitive disorders, memory impairment, and memory deficit.